Nutrient quality
The substantial extract amount and focused composition fit the intended use well. Unspecified boswellic-acid strength and lack of absorption support limit confidence in effective potency.
| $ 14.29 | ||
| $ 12.99 | ||
Vitacost | $ 14.29 |
Each capsule supplies 600 mg of Boswellia serrata gum-resin extract. The substantial extract amount and single-ingredient design provide focused, economical Boswellia use.
Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.
Boswellic-acid percentage, AKBA yield, and absorption support are not disclosed, so the active potency cannot be judged from the large headline amount. The 120-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.
The substantial extract amount and focused composition fit the intended use well. Unspecified boswellic-acid strength and lack of absorption support limit confidence in effective potency.
The active amount is clear and no proprietary blend is used. Missing potency standards, directions, and non-active ingredients leave important label details incomplete.
The supplied average rating is strong and the rating volume is moderate. No specific experience details were provided to judge repeated complaints or purpose alignment.
A large extract amount at an efficient serving cost provides good practical value. Better standardization would make the comparison with higher-quality Boswellia products more reliable.
Boswellia directly targets the 5-LOX pathway and is closely aligned with inflammation-focused support. The large extract amount is useful, but no boswellic-acid percentage or AKBA yield is stated.
The focused formula may provide meaningful depth despite uncertain active-compound potency. Boswellia may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.
Boswellia directly targets the 5-LOX inflammatory pathway relevant to joint pain and stiffness. Standardized boswellia extracts have strong human evidence for improving osteoarthritis comfort and function.
The 600 mg extract amount is substantial, but the actual boswellic acid and AKBA yields are unknown. The plant and extract amount are clear, while missing standardization and absorption support limit form quality.
| Ingredient | Amount per serving |
|---|---|
Boswellia serrata Gum Resin Extract (Boswellic Acids) | 600 mg |
A large Boswellia extract amount is provided, but the label does not state a boswellic acid percentage. Boswellic acids are named without AKBA detail, and the capsule has no absorption enhancer. The low serving cost provides good practical value despite incomplete potency information.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.